105 related articles for article (PubMed ID: 16289004)
1. Smad3 phosphorylation by cyclin-dependent kinases.
Liu F
Cytokine Growth Factor Rev; 2006; 17(1-2):9-17. PubMed ID: 16289004
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
[TBL] [Abstract][Full Text] [Related]
3. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
4. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.
Roberts AB; Tian F; Byfield SD; Stuelten C; Ooshima A; Saika S; Flanders KC
Cytokine Growth Factor Rev; 2006; 17(1-2):19-27. PubMed ID: 16290023
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Smad antiproliferative function by CDK phosphorylation.
Liu F; Matsuura I
Cell Cycle; 2005 Jan; 4(1):63-6. PubMed ID: 15611645
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene.
Li H; Liu JP
Ann N Y Acad Sci; 2007 Oct; 1114():56-68. PubMed ID: 17934056
[TBL] [Abstract][Full Text] [Related]
7. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
8. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.
Li P; Wang D; Lucas J; Oparil S; Xing D; Cao X; Novak L; Renfrow MB; Chen YF
Circ Res; 2008 Feb; 102(2):185-92. PubMed ID: 17991884
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP/protein kinase G phosphorylation of Smad3 blocks transforming growth factor-beta-induced nuclear Smad translocation: a key antifibrogenic mechanism of atrial natriuretic peptide.
Buxton IL; Duan D
Circ Res; 2008 Feb; 102(2):151-3. PubMed ID: 18239144
[No Abstract] [Full Text] [Related]
12. Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.
Prokova V; Mavridou S; Papakosta P; Petratos K; Kardassis D
Biochemistry; 2007 Dec; 46(48):13775-86. PubMed ID: 17994767
[TBL] [Abstract][Full Text] [Related]
13. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
[TBL] [Abstract][Full Text] [Related]
15. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
Yang Y; Yang S; Chen M; Zhang X; Zou Y; Zhang X
J Ethnopharmacol; 2008 Jul; 118(2):264-70. PubMed ID: 18502066
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
[TBL] [Abstract][Full Text] [Related]
17. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Yu Z; Xing Y
Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
[TBL] [Abstract][Full Text] [Related]
19. [The role of transforming growth factor-beta1/Smad3 signaling in bronchiolitis obliterans following lung transplantation].
Liu HX; Li Y; Zhao CH; Liu Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2069-73. PubMed ID: 17925182
[TBL] [Abstract][Full Text] [Related]
20. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
Li L; Iwamoto Y; Berezovskaya A; Boussiotis VA
Nat Immunol; 2006 Nov; 7(11):1157-65. PubMed ID: 17013388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]